Horizon Therapeutics (HZNP) PT Raised to $144 at BofA Securities on Derisked Krystexxa
Tweet Send to a Friend
BofA Securities analyst Jason Gerberry raised the price target on Horizon Therapeutics (NASDAQ: HZNP) to $144.00 (from $141.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
